Showing results (371-380 of 752) with videos related to
Sort By:
Pageof 76
Journal of Cataract and Refractive Surgery|July 22, 2019
Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucomaJason Jones, Douglas D Koch, Steven Vold, et al.Frontiers in Microbiology|July 22, 2017
A Novel and Validated Protocol for Performing MIC Tests to Determine the Susceptibility of Piscirickettsia salmonis Isolates to Florfenicol and OxytetracyclineSergio Contreras-Lynch, Peter Smith, Paola Olmos, et al.European Journal of Clinical Pharmacology|April 17, 2008
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteersCatherine Orrell, Francesca Little, Peter Smith, et al.Chronobiology International|May 12, 2006
High-intensity red light suppresses melatoninJohn P Hanifin, Karen T Stewart, Peter Smith, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 20, 2014
Biodistribution and delivery efficiency of unmodified tumor-derived exosomesTyson Smyth, Max Kullberg, Noeen Malik, et al.Annals of Work Exposures and Health|March 20, 2018
Gender/Sex Differences in the Relationship between Psychosocial Work Exposures and Work and Life StressKathy Padkapayeva, Mahée Gilbert-Ouimet, Amber Bielecky, et al.Journal of Biomolecular Screening|February 8, 2011
Comparison of 2 cell-based phosphoprotein assays to support screening and development of an ALK inhibitorAllison E Drew, Samer Al-Assaad, Violeta Yu, et al.Critical Reviews in Toxicology|October 24, 2009
A 1-year toxicity study in dogs is no longer a scientifically justifiable core data requirement for the safety assessment of pesticidesWerner Kobel, Ivana Fegert, Richard Billington, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozoleWilliam R Miller, Alexey Larionov, Lorna Renshaw, et al.BMC Cancer|September 15, 2005
Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumoursVictoria A L Tomlinson, Helen J Newbery, Naomi R Wray, et al.Pageof 76